Monoclonal Antibody Development and Manufacturing

Mariposa Bioscience, Inc. was founded in mid 2006 by Robert Pytela and Jacinto Villanueva. Mariposa Bioscience has developed, and now firmly established, a new technology for obtaining monoclonal antibodies directly from peripheral blood B cells of non-rodent species (primarily rabbit and chicken). The company’s business has focused on contract antibody development, primarily for major suppliers in the immunohistochemistry/in vitro diagnostics field, as well for university laboratories. In ad...

Mariposa Bioscience, Inc. was founded in mid 2006 by Robert Pytela and Jacinto Villanueva. Mariposa Bioscience has developed, and now firmly established, a new technology for obtaining monoclonal antibodies directly from peripheral blood B cells of non-rodent species (primarily rabbit and chicken). The company’s business has focused on contract antibody development, primarily for major suppliers in the immunohistochemistry/in vitro diagnostics field, as well for university laboratories. In addition, Mariposa Bioscience is also actively pursuing in-house research and development, focusing on further technology improvement, high-throughput antibody development, and discovery of antibodies against novel cancer bio-markers for research, diagnostic and therapeutic purposes.